Discover 1,760 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,760
Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section
for
Pruritus Caused by Drug
Location: Detroit MI
Sponsor: Wayne State University
Sex: Female
Age: 18 - 50
Code: NCT06297499
Phase 1, Recruiting
Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal Odor Not Caused by BV or Vaginitis
for
Vaginal Odor
Location: Detroit MI, Winston Salem NC, Philadelphia PA
Sponsor: Abbott Research Group
Sex: Female
Age: 18+
Code: NCT00417365
Recruiting
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
for
Hypertension (HTN)
Location: Troy MI, Chicago IL, Ft. Washington MD, Berlin NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07543120
Phase 2, Recruiting
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Location: Detroit MI, Columbus OH, St Louis MO, Rochester MN,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07393282
Phase 3, Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for
Prostate Cancer
Location: Detroit MI, Gahanna OH, Chicago IL, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06855277
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
for
Metastatic Colorectal Adenocarcinoma
Location: Detroit MI, Clarkston MI, Macomb MI, Lansing MI,
Sponsor: Barbara Ann Karmanos Cancer Institute
Sex: All
Age: 22+
Code: NCT07130903
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Detroit MI, Dayton OH, Chicago IL, Rochester NY,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase 3, Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Detroit MI, Grand Rapids MI, Indianapolis IN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase 1, Recruiting
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Detroit MI, Cleveland OH, Cincinnati OH, Madison WI,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06859762
Phase 1, Recruiting
Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies
for
Advanced Solid Tumor
Location: Detroit MI, Clarkston MI, Macomb MI, Lansing MI,
Sponsor: Barbara Ann Karmanos Cancer Institute
Sex: All
Age: 18+
Code: NCT07098299
Phase 1, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Detroit MI, Kalamazoo MI, Cleveland OH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase 3, Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
for
Urothelial Cancer
Location: Detroit MI, Cleveland OH, Mayfield Heights OH,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07106762
Phase 2, Phase 3, Recruiting
A Study to Assess the Safety, Tolerability and Efficacy of ION775
for
Hypertriglyceridemia, Severe Hypertriglyceridemia
Location: Flint MI, Munroe Falls OH, Carmel IN, Louisville KY,
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07604974
Phase 2, Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
for
Chronic Lymphocytic Leukemia (CLL),
Location: Detroit MI, Fort Wayne IN, Cleveland OH, Columbus OH,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07221500
Phase 2, Recruiting
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
for
Relapsed/Refractory Small Cell Lung Cancer
Location: Detroit MI, Cleveland OH, Buffalo NY, Nashville TN,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07325136
Phase 1, Phase 2, Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
for
Follicular Lymphoma (FL)
Location: Detroit MI, Cleveland OH, Noblesville IN,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06091254
Phase 3, Recruiting
Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements
for
Parkinson Disease, Atypical Parkinsonism
Location: East Lansing MI
Sponsor: Michigan State University
Sex: All
Age: 50+
Code: NCT07599696
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Detroit MI, Fort Wayne IN, Dyer IN, Chicago IL,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
for
Female Breast Cancer, Prostate Cancer, Colorectal Carcinoma
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute
Sex: All
Age: 20 - 70+
Code: NCT07436078
Recruiting
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
for
Esophageal Squamous Cell Carcinoma,
Location: Detroit MI, Fairfax VA, Nashville TN, Denver CO,